BioSpace News Archive

Business

PFIZER REPORTS SECOND-QUARTER 2018 RESULTS

Second-Quarter 2018 Revenues of $13.5 Billion, Reflecting 2% Operational Growth

July 31, 2018
·
46 min read
BioMidwest

Roche to showcase how labs are driving change across health networks to address PAMA and other challenges at AACC 2018 Clinical Lab Expo

Featured labs address challenges by streamlining processes, reducing costs and optimizing operations while ensuring delivery of care

July 31, 2018
·
6 min read
Biotech Bay

Glaucoma Research Foundation Grant Leads to Major Breakthrough in Neuron Regeneration

Study indicates treatment using insulin may restore vision in glaucoma patients.

July 31, 2018
·
4 min read
Pharm Country

European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection

Opdivo is the first and only PD-1 agent with an approved adjuvant therapy indication in the European Union

July 31, 2018
·
32 min read
Business

Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs

Total product-related revenues of $421 million in Q2 2018, representing 29 percent growth over the same period last year

July 31, 2018
·
25 min read
Pharm Country

CytoSorbents Expands Distribution of CytoSorb® to a Total of 53 Countries Worldwide

CytoSorbents Corporation, announced that it has expanded the distribution of CytoSorb® to a total of 53 countries worldwide.

July 31, 2018
·
4 min read
BioMidwest

InSitu Biologics Launches Regulation A+ Investment Opportunity for Non-Opiate Painkiller AnestaGel™

InSitu Biologics, LLC has launched a $10 million stock offering using Regulation A+.

July 31, 2018
·
2 min read
ProMIS Neurosciences Issues White Paper Entitled ‘State of the Art at AAIC 2018'

Key conference theme: targeting toxic amyloid-beta oligomers offers renewed hope for treatment of Alzheimer’s disease

July 31, 2018
·
4 min read
Drug Development

Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Cancer

Progression free survival of patients treated with Tumor Treating Fields plus weekly paclitaxel was more than double that of weekly paclitaxel-treated historical controls.

July 31, 2018
·
5 min read
Policy

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

The TIGERTRIEVER 13 is the smallest profile stentriever, designed to safely retrieve clots from intracranial vessels of 1mm - 2.5mm.

July 31, 2018
·
2 min read